First Wave BioPharma Inc (FWBI) Company Profile & Statistics

First Wave BioPharma Inc
FWBI
(Nasdaq - US)
N/A
2.77
-0.20 (-6.73%)
in:usd•As of: May 15, 2024 15:59 UTC -4
Open
2.96
High
2.96
Low
2.74

About First Wave BioPharma Inc

CEO

James Sapirstein

Headquarters

777 yamato road, suite 502

boca raton, fl 33431, united states

Auditor

Mazars USA LLP

Employees

Share Holders

149

Website

www.firstwavebio.com

Industry

biotechnology

Sector

health technology

Company Overview

First Wave BioPharma Inc. is a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases. First Wave BioPharma Inc., formerly known as AzurRx BioPharma Inc., is based in BOCA RATON, Fla.

First Wave BioPharma Inc Statistics

Valuation Measures

Market Capitalization ²	5.62M
Enterprise Value	2.52M
Enterprise Value/EBITDA (ttm)	-0.16
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	1.30
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-603.03%
Return on Invested Capital (ttm)	-843.62%
Return on Assets (ttm)	-278.67%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-15.74M
Net Income Avi to Common (ttm)	-16.10M
Diluted EPS (ttm)	-272.80

Share Statistics

Beta (5Y Monthly)	1.28
52-Week Change	-94.91%
S&P500 52-Week Change	28.33%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	2.03M
Dividend Yield	0.00%
Float ⁴	2.02M
% Held by Insiders	0.49%
% Held by Institutions	12.30%

Balance Sheet

Total Cash (mrq)	3.71M
Total Cash Per Share (mrq)	1.83
Total Debt (mrq)	612.80K
Total Debt/Equity (mrq)	17.01%
Current Ratio (mrq)	1.58%
Quick Ratio (mrq)	1.58%
Book Value Per Share (mrq)	2.31

Cash Flow

Operating Cash Flow Per Share (ytd)	-36.80
Free Cash Flow (ytd)	-12.38M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

First Wave BioPharma Inc

Trade With A Regulated Broker